Blues health insurers put up $55 million to take on generic drug makers
NEW YORK (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that ...
NEW YORK (Reuters) - A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that ...
(Reuters) - India's drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca ...
FILE PHOTO: A cement silo of Mexican cement maker CEMEX is pictured at a cement plant in Monterrey, Mexico February ...
FILE PHOTO: Delta airlines logo is seen inside of the Commodore Arturo Merino Benitez International Airport in Santiago, Chile April ...
By Mathieu Rosemain, Douglas BusvinePARIS/BERLIN (Reuters) - France and the Netherlands on Thursday called for a European Union authority to ...
Japan's Minister in charge of administrative reform and regulatory reform Taro Kono attends a news conference in Tokyo, Japan, September ...
(Reuters) - AstraZeneca said on Tuesday it will publish up-to-date results from its latest COVID-19 vaccine trial after U.S. health ...
LONDON (Reuters) - Britain’s status quo transition period with the European Union will end at 2300 GMT on Dec. 31.FILE ...
© 2023 Mapafisico.com